Any Ideas are Welcome : Today's News

Pfizer Inc said on Monday its COVID-19 vaccine provided strong long-term protection against the virus in a late-stage study conducted among adolescents aged 12 to 15. A two-dose series of the vaccine was 100% effective against COVID-19, measured seven days through over four months after the second dose, the company said. The long-term data will support planned submissions for full-regulatory approval of the vaccine in the age group in the United States and worldwide. Pfizer and BioNTech will seek clearance for a 30 micrograms dose of the vaccine for those aged 12 and above. The vaccine was authorized for emergency use in people 12 to 15 years old by the U.S. Food & Dr...

Keep on reading: Pfizer’s COVID-19 vaccine trial data shows long-term efficacy in adolescents
Sponsored Links : Snapchat Generator - Grab snapchat pass,photos,contacts and more for free.

Tiktok Booster - trends start here. Free Tiktok Followers, Likes, Views!

Resurge.com– The Resurge supplement is formulated to deliver fat-burning properties to help one lose weight in a short period.